A Study to Evaluate Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis (IA) or Invasive Mucormycosis (IM) in Pediatric Participants
Clinical trial NCT03816176 · COMPLETED
Trial details
- NCT number
- NCT03816176
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-22
- Primary completion
- 2022-12-14
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.